(Q43546708)

English

Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group (English)

1 reference

Europe PubMed Central

24 November 2017

0 references

author name string

J Assies

1

1 reference

Europe PubMed Central

24 November 2017

R Lieverse

2

1 reference

Europe PubMed Central

24 November 2017

P Vreken

3

1 reference

Europe PubMed Central

24 November 2017

R J Wanders

4

1 reference

Europe PubMed Central

24 November 2017

P M Dingemans

5

1 reference

Europe PubMed Central

24 November 2017

D H Linszen

6

1 reference

Europe PubMed Central

24 November 2017

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

24 November 2017

Biological Psychiatry

1 reference

Europe PubMed Central

24 November 2017

49

1 reference

Europe PubMed Central

24 November 2017

510-522

1 reference

Europe PubMed Central

24 November 2017

6

1 reference

Europe PubMed Central

24 November 2017

Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Nervonic acid in red blood cell sphingomyelin in premature infants: an index of myelin maturation?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Dietary alpha-linolenic acid at 1.3 g/kg maintains maximal docosahexaenoic acid concentration in brain, heart and liver of adult rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Nutritional and hormonal factors influencing desaturation of essential fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

High fat diets varying in ratios of polyunsaturated to saturated fatty acid and linoleic to linolenic acid: a comparison of rat neural and red cell membrane phospholipids.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Fat consumption and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

The fatty acid chain elongation system of mammalian endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Measurement of very long-chain fatty acids, phytanic and pristanic acid in plasma and cultured fibroblasts by gas chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Dietary omega-3 polyunsaturated fatty acids reduce IFN-gamma receptor expression in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Membrane fatty acids, niacin flushing and clinical parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Membrane abnormalities in the psychoses and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Possible relevance of phospholipid abnormalities and genetic interactions in psychiatric disorders: the relationship between dyslexia and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

The membrane hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Essential fatty acids in growth and development

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

The triggering signal dictates the effect of docosahexaenoic acid on lymphocyte function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Lipids, membrane receptors, and enzymes: effects of dietary fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Fatty acids and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Essential fatty acid deficiency in parenterally fed preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Effect of in vivo modulation of membrane docosahexaenoic acid levels on the dopamine-dependent adenylate cyclase activity in the rat retina.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Trifluoperazine increases fatty acid turnover in phospholipids in cultured human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Potentiation of NMDA receptor currents by arachidonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

A neurodevelopmental approach to the classification of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Functional modulation of human recombinant gamma-aminobutyric acid type A receptor by docosahexaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Fatty acid profiles in mental disease. Part 1. Linolenate variations in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Dietary fatty acids--the N-6/N-3 balance and chronic elderly diseases. Excess linoleic acid and relative N-3 deficiency syndrome seen in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Serotonin-induced endothelial cell proliferation is blocked by omega-3 fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

The effects of cigarette smoking on the metabolism of essential fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Sustained Remission of Positive and Negative Symptoms of Schizophrenia Following Treatment With Eicosapentaenoic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Hypothyroidism and thyroxin substitution affect the n−3 fatty acid composition of rat liver mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

The nervous system has an absolute molecular species requirement for proper function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Nervonic acid and demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Effects of neuroleptics on the lipid peroxidation and peroxide metabolism enzyme activities in various discrete areas of the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Recent advances in the biochemistry and molecular biology of fatty acyl desaturases.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Schizophrenia, tardive dyskinesia and essential fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Lipids and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Fatty acids and brain peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900986-0

7 January 2021

Identifiers

10.1016/S0006-3223(00)00986-0

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43546708&oldid=2098230302"